Identifying the mechanisms of action driving a drug’s anti-cancer efficacy is critical for identifying optimal biomarkers, indications, and combinations for clinical success. Yet, systematically ...

Abivax receives a "Strong Buy" rating, driven by positive phase 3 ABTECT induction data for obefazimod in moderate-to-severe ...

The GNPS Drug Library may be more broadly applicable for drug screening across diverse research disciplines, such as food and environmental monitoring.

A meta-analysis of 80,737 cases identifies five new variants and 22 risk genes, highlighting three potential drug targets for ...

New findings out of King’s College London suggest that certain fiber-rich foods may help improve motility, soften stool, and ...

Crofelemer can potentially extend lives of MVID patients – infants and children who face the lethal natural history of the disease Parenteral support reduction of up to 37% is groundbreaking; No ...

New Zealanders under 50 are being diagnosed with bowel cancer too late, too often – and their voices reveal the human cost of delayed diagnosis A new nationwide report from Bowel Cancer New Zealand ...

An update from SinoMab Bioscience Ltd. ( ($HK:3681) ) is now available. SinoMab BioScience Limited announced that its Investigational New Drug ...

A new oral GLP-1 receptor agonist, orforglipron, is revolutionizing weight management by offering a needle-free alternative ...

Gabriel Schwartz, MSN, NP, explains how mechanisms of action determine the safety of systemic treatments in metastatic colorectal cancer post chemotherapy.

What if the race to get thin was quietly putting health at risk? That question is becoming harder to ignore as glucagon‑like ...

Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM ESTCompany ParticipantsDietmar Berger - Chief ...